Bringing the fundamentals into focus…
Back to Organon & Co.
How Organon & Co. stacks up
OGN · against 290 other Healthcare companies of similar size
Overall
43/ 100
Below the middle of the pack.
Ranked #213 of 291 · scores higher than 26% of peers
Bars: peers in each 10-point band of the overall score45 peers with an overall score of 40–49, including OGN · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around OGN| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 2 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 4 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 5 | 19.7B HKD (≈$2.5B) | 84 | 84 | 98 | 87 | 0 / 2 | |
| 213 | 13.4B CNY (≈$1.9B) | 43 | 73 | 24 | 48 | 2 / 2 | |
| 213 | 7.2B USD | 43 | 48 | 57 | 40 | 2 / 2 | |
| 213 | 5.5B USD | 43 | 53 | 24 | 76 | 2 / 2 | |
| 213 | 2.6B USD | 43 | 8 | — | 21 | 0 / 2 | |
| 213 | 3.6B USD | 43 | 85 | 15 | 69 | 2 / 2 | |
| 218 | 29.2B CNY (≈$4.1B) | 42 | 40 | 11 | 47 | 0 / 2 | |
| 218 | 3.1B EUR (≈$3.4B) | 42 | 67 | 25 | 63 | 2 / 2 | |
| 218 | 4.1B USD | 42 | 8 | — | 22 | 0 / 2 | |
| 218 | 2.0B USD | 42 | 8 | — | 24 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score